Search Results - "Kielgast, Urd"

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity by Hagemann, Christoffer A, Legart, Christian, Møllerhøj, Mathias B, Madsen, Martin R, Hansen, Henrik H, Kønig, Merete J, Helgstrand, Frederik, Hjørne, Flemming P, Toxværd, Anders, Langhoff, Jill L, Kielgast, Urd L, Gluud, Lise L, Ægidius, Helene, Rigbolt, Kristoffer T. G, Vilsbøll, Tina, Jelsing, Jacob, Knop, Filip K

“…Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present…”
Get full text

Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass by Øhrstrøm, Caroline C., Worm, Dorte, Kielgast, Urd Lynge, Holst, Jens Juul, Hansen, Dorte L.

“…Background Early dumping and post-bariatric hypoglycemia (PBH) are often addressed as two separate postprandial complications after Roux-en-Y gastric bypass…”
Get full text

Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial by Nielsen, Casper K, Øhrstrøm, Caroline C, Kielgast, Urd L, Hansen, Dorte L, Hartmann, Bolette, Holst, Jens J, Lund, Asger, Vilsbøll, Tina, Knop, Filip K

“…To investigate the efficacy and safety of dasiglucagon, a novel stable glucagon analog in a liquid formulation, in Roux-en-Y gastric bypass (RYGB)-operated…”
Get full text

A Low Dose of Pasireotide Prevents Hypoglycemia in Roux-en-Y Gastric Bypass-Operated Individuals by Øhrstrøm, Caroline C., Hansen, Dorte L., Kielgast, Urd Lynge, Hartmann, Bolette, Holst, Jens Juul, Worm, Dorte

“…Post-bariatric hypoglycemia (PBH) can be a serious complication after Roux-en-Y gastric bypass (RYGB), and treatment with somatostatin analogs has been…”
Get full text

Treatment of type 1 diabetic patients with glucagon-like peptide-1 (GLP-1) and GLP-1R agonists by Kielgast, Urd, Holst, Jens J, Madsbad, Sten

“…GLP-1 (glucagon-like peptide-1) is a peptide hormone secreted from endocrine cells in the intestinal mucosa in response to meals. The major effects of GLP-1…”
Get more information

A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity by Christoffer A. Hagemann, Christian Legart, Mathias B. Møllerhøj, Martin R. Madsen, Henrik H. Hansen, Merete J. Kønig, Frederik Helgstrand, Flemming P. Hjørne, Anders Toxværd, Jill L. Langhoff, Urd L. Kielgast, Lise L. Gluud, Helene Ægidius, Kristoffer T. G. Rigbolt, Tina Vilsbøll, Jacob Jelsing, Filip K. Knop

“…Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present…”
Get full text

Four Weeks of Treatment With Liraglutide Reduces Insulin Dose Without Loss of Glycemic Control in Type 1 Diabetic Patients With and Without Residual β-Cell Function by Kielgast, Urd, Krarup, Thure, Holst, Jens Juul, Madsbad, Sten

“…OBJECTIVE: To investigate the effect of 4 weeks of treatment with liraglutide on insulin dose and glycemic control in type 1 diabetic patients with and without…”
Get full text

Antidiabetic Actions of Endogenous and Exogenous GLP-1 in Type 1 Diabetic Patients With and Without Residual β-Cell Function by KIELGAST, Urd, HOLST, Jens J, MADSBAD, Sten

“…To investigate the effect of exogenous as well as endogenous glucagon-like peptide 1 (GLP-1) on postprandial glucose excursions and to characterize the…”
Get full text

Quality of Life is Markedly Impaired by Rheumatological and Skin Manifestations in Patients with Type 1 Diabetes: A Questionnaire Survey by Nørgaard, Kirsten, Kielgast, Urd

“…Introduction To estimate lifetime prevalence of diabetes-related upper limb and non-acquired skin manifestations in a representative type 1 diabetes (T1D)…”
Get full text

Postprandial hypoglycaemia after Roux‐en‐Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide by Øhrstrøm, Caroline Christfort, Worm, Dorte, Højager, Anna, Andersen, Ditte, Holst, Jens Juul, Kielgast, Urd Lynge, Hansen, Dorte Lindqvist

“…Aim To investigate the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide on post‐bariatric hypoglycaemia (PBH) after Roux‐en‐Y gastric…”
Get full text

Kinetics of insulin and C-peptide and estimation of prehepatic insulin secretion rates after intravenous glucose stimulation using arterial versus venous blood sampling in healthy males by Wriedt, Emil Brink, Kielgast, Urd, Svane, Maria S, Møller, Søren, Madsbad, Sten

“…An intravenous glucose-infusion of 0.3 g glucose per Kg body weight was administered over 1 min in nine healthy males with simultaneous blood sampling from the…”
Get full text

A Response to “The Relationship Between Sleep and Quality of Life in Type 1 Diabetes Patients” by Nørgaard, Kirsten, Kielgast, Urd

Get full text

Acarbose and Pasireotide Reduce Hypoglycemia in Roux-en-Y Gastric Bypass Operated Subjects by ØHRSTRÔM, CAROLINE, KIELGAST, URD, HOLST, JENS J., WORM, DORTE, HANSEN, DORTE L.

“…Introduction: Hypoglycemia is a severe complication after Roux-en-Y gastric bypass (RYGB), with no effective treatment options. We investigated the glucose…”
Get full text

2073-P: Are Early Dumping and Postprandial Hypoglycemia after Roux-en-Y Gastric Bypass Related Events? by ØHRSTRÔM, CAROLINE, WORM, DORTE, KIELGAST, URD, HOLST, JENS J., HANSEN, DORTE L.

“…Introduction: Early dumping (ED) and postprandial hypoglycemia (PH) are often addressed as two separate complications after Roux-en-Y gastric bypass (RYGB)…”
Get full text

Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial by Dejgaard, Thomas F., Frandsen, Christian S., Kielgast, Urd, Størling, Joachim, Overgaard, Anne J., Svane, Maria S., Olsen, Markus Harboe, Thorsteinsson, Birger, Andersen, Henrik U., Krarup, Thure, Holst, Jens J., Madsbad, Sten

“…Aim To test the effect of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on residual beta‐cell function in adults with newly diagnosed type 1…”
Get full text

10-LB: Dasiglucagon Ameliorates Postprandial Hypoglycemia after Roux-en-y Gastric Bypass by NIELSEN, CASPER K., OEHRSTROEM, CAROLINE, KIELGAST, URD, HANSEN, DORTE L., LUND, ASGER, VILSBØLL, TINA, KNOP, FILIP K.

“…Introduction: Postprandial hypoglycemia is a frequent and debilitating complication following Roux-en-Y gastric bypass (RYGB) without effective treatments. In…”
Get full text

396-P: Real-Life Evaluation of Sodium–Glucose Cotransporter 2 Inhibition in Type 1 Diabetes by STOUGAARD, ELISABETH BUUR, KRISTENSEN, PETER L., KIELGAST, URD, ANDERSEN, SR., HENRIK U., HAMID, YASMIN H., GÆDE, PETER, SØNDERGAARD, ESBEN, DØRFLINGER, GRY, FJELDBORG, KAREN K., HANSEN, KLAVS W., THOMSEN, HENRIK H., AL-IMARI, THURAYA, RØDER, MICHAEL, ROSSING, PETER, PERSSON, FREDERIK

“…Background: The indication for treatment of type 1 diabetes (T1D) with the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin has been withdrawn…”
Get full text

Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients by Kielgast, Urd, Asmar, Meena, Madsbad, Sten, Holst, Jens J.

“…Context: The mechanism by which glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion is uncertain, and it is not determined whether endogenous insulin…”
Get full text

Counterregulatory responses to postprandial hypoglycemia after Roux-en-Y gastric bypass by Øhrstrøm, Caroline C., Hansen, Dorte L., Kielgast, Urd Lynge, Bergmann, Marianne Lerbæk, Veedfald, Simon, Holst, Jens Juul, Worm, Dorte

“…Postbariatric hypoglycemia (PBH) is a potentially serious complication after Roux-en-Y gastric bypass (RYGB), and impaired counterregulatory hormone responses…”
Get full text

59-OR: Liraglutide Preserved Insulin Secretion in Adults with Newly Diagnosed Type 1 Diabetes: The NewLira Trial by DEJGAARD, THOMAS F., FRANDSEN, CHRISTIAN S., KIELGAST, URD, ANDERSEN, HENRIK U., THORSTEINSSON, BIRGER, KRARUP, THURE, HOLST, JENS J., MADSBAD, STEN

“…Glucagon-like peptide-1 (GLP-1) stimulates insulin secretion in adults with type 1 diabetes and residual beta-cell function. This randomized, double-blind,…”
Get full text